S&P 5007,428.78▲0.2% Nasdaq24,876.91▼0.2% Dow52,747.32▲1.0% Russell 2K2,953.80▲0.2% 10-Yr4.60%−4bp VIX18.21−0.46 WTI$81.23▼1.7% Gold$4,023.80▼1.2% EUR/USD1.139▼0.1% BTC$63,409▼0.7% Nikkei64,931▲0.5%
At close · Tue, Jul 28, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›Drugmaker sheds $27 billion in market value after fail…

Drugmaker sheds $27 billion in market value after failed trial

Reported · Written up by our desk · Previews

A major drugmaker lost about $27 billion in market value after a trial failed, according to MarketWatch.

← Newer storyBitcoin ETFs see sell-off ease after $2.7B outflows

More like this

EarningsRoot investor letter highlights persistent commercial auto headwinds
EarningsChipotle raises same-store sales forecast as customer traffic returns
EarningsAmazon deprecates most Nova AI models, shifts toward frontier model
EarningsChipotle and Starbucks set for earnings, with investors watching key metrics
EarningsFord’s truck push draws fresh attention from Wall Street

Sources

MarketWatchMajor drugmaker loses $27 billion in market value after failed trial
MarketWatchMajor drugmaker loses $27 billion in market value after failed trial

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.